SHC - Sotera Health Co
IEX Last Trade
13.45
-0.020 -0.149%
Share volume: 26,129
Last Updated: Fri 27 Dec 2024 08:30:30 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$13.47
-0.02
-0.15%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-04 | 2022-11-02 | 2023-02-28 | 2023-05-03 | 2023-08-03 | 2023-11-01 | 2024-02-27 | 2024-05-02 | |
Assets | |||||||||
Total Assets | 2.840 B | 2.811 B | 3.118 B | 3.414 B | 3.075 B | 3.037 B | 3.130 B | 3.060 B | |
Current Assets | 398.681 M | 420.734 M | 645.010 M | 923.799 M | 546.692 M | 519.646 M | 557.244 M | 487.179 M | |
Inventories | 39.652 M | 37.153 M | 37.145 M | 46.736 M | 42.102 M | 37.924 M | 48.316 M | 51.342 M | |
Other Current Assets | 81.173 M | 81.673 M | 80.995 M | 80.928 M | 81.995 M | 84.201 M | 53.846 M | 53.663 M | |
Short Term Investments | 81.173 M | 81.673 M | 80.995 M | 80.928 M | 81.995 M | 84.201 M | 53.846 M | 53.663 M | |
Total Receivables | 137.238 M | 136.947 M | 130.576 M | 135.955 M | 152.105 M | 144.987 M | 153.428 M | 119.354 M | |
Current Cash | 139.564 M | 163.975 M | 395.214 M | 647.948 M | 262.700 M | 244.959 M | 296.407 M | 261.133 M | |
Total Non-current Assets | 2.441 B | 2.390 B | 2.473 B | 2.490 B | 2.528 B | 2.517 B | 2.573 B | 2.573 B | |
Property Plant Equipment | 699.571 M | 704.406 M | 774.527 M | 816.164 M | 859.138 M | 884.385 M | 946.914 M | 979.422 M | |
Other Assets | 47.096 M | 56.987 M | 74.553 M | 69.824 M | 73.086 M | 73.905 M | 69.724 M | 72.383 M | |
Intangible Assets | 543.057 M | 503.755 M | 491.265 M | 471.860 M | 456.120 M | 429.112 M | 416.318 M | 390.457 M | |
Goodwill | 1.116 B | 1.092 B | 1.102 B | 1.103 B | 1.110 B | 1.101 B | 1.111 B | 1.103 B | |
Liabilities and shareholders’ equity | |||||||||
Total Liabilities and shareholders’ equity | 2.840 B | 2.811 B | 3.118 B | 3.414 B | 3.075 B | 3.037 B | 3.130 B | 3.060 B | |
Total liabilities | 2.204 B | 2.204 B | 2.767 B | 3.053 B | 2.657 B | 2.659 B | 2.687 B | 2.630 B | |
Total current liabilities | 142.021 M | 140.031 M | 791.567 M | 600.149 M | 200.330 M | 200.594 M | 230.654 M | 152.340 M | |
Accounts Payable | 65.271 M | 60.730 M | 74.139 M | 61.939 M | 55.580 M | 57.125 M | 71.039 M | 61.576 M | |
Other liabilities | 89.700 M | 88.488 M | 82.229 M | 85.044 M | 84.171 M | 83.001 M | 84.024 M | 83.207 M | |
Current long term debt | 1.615 M | 1.591 M | 198.841 M | 12.619 M | 13.830 M | 13.633 M | 13.568 M | 6.298 M | |
Long term debt | 1.803 B | 1.801 B | 1.804 B | 2.284 B | 2.283 B | 2.286 B | 2.287 B | 2.315 B | |
Other liabilities | 89.700 M | 88.488 M | 82.229 M | 85.044 M | 84.171 M | 83.001 M | 84.024 M | 83.207 M | |
Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total Shareholder equity | 636.000 M | 606.729 M | 350.238 M | 361.125 M | 418.367 M | 377.471 M | 443.734 M | 429.392 M | |
Common stock | 279.990 M | 280.142 M | 280.423 M | 280.691 M | 280.893 M | 281.105 M | 281.343 M | 281.913 M | |
Retained earnings | -411.187 M | -386.097 M | -705.816 M | -702.974 M | -679.461 M | -693.121 M | -654.440 M | -648.117 M |